{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:26:51Z","timestamp":1762100811175},"reference-count":49,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.ejphar.2008.04.028","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T20:35:19Z","timestamp":1208464519000},"page":"316-324","source":"Crossref","is-referenced-by-count":32,"title":["Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects"],"prefix":"10.1016","volume":"588","author":[{"given":"Seiichiro","family":"Kurita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguhito","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Matsuzawa-Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Nabemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Misu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuni","family":"Nakanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.04.028_bib1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.028_bib2","doi-asserted-by":"crossref","first-page":"G642","DOI":"10.1152\/ajpgi.00037.2003","article-title":"Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver","volume":"285","author":"Bataller","year":"2003","journal-title":"Am. J. Physiol.: Gasterointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","article-title":"Activated human hepatic stellate cells express the renin\u2013angiotensin system and synthesize angiotensin II","volume":"125","author":"Bataller","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis","volume":"112","author":"Bataller","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.04.028_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib50","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","author":"Bosch","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.04.028_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2001-12925","article-title":"Nonalcoholic steatohepatitis: definition and pathology","volume":"21","author":"Brunt","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejphar.2008.04.028_bib7","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib9","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/diacare.28.7.1690","article-title":"Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy","volume":"28","author":"Chiarelli","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2008.04.028_bib10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1172\/JCI116827","article-title":"Myometrial angiotensin II receptor subtypes change during ovine pregnancy","volume":"92","author":"Cox","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.04.028_bib11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.gastro.2006.05.048","article-title":"NADPH oxidase in the liver: defensive, offensive, or fibrogenic?","volume":"131","author":"De Minicis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistanceA multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2008.04.028_bib14","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib15","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","volume":"275","author":"Friedman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.04.028_bib16","first-page":"825","volume":"48","author":"Garcia-Ruiz","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","article-title":"Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis","volume":"39","author":"George","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.21638","article-title":"Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis","volume":"45","author":"Hirose","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib19","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2008.04.028_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb1111","article-title":"SREBPs suppress IRS-2-mediated insulin signalling in the liver","volume":"6","author":"Ide","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0006-291X(03)01357-3","article-title":"AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl(4)","volume":"308","author":"Kanno","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2008.04.028_bib22","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/diabetes.41.11.1422","article-title":"Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long\u2013Evans Tokushima Fatty (OLETF) strain","volume":"41","author":"Kawano","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2008.04.028_bib23","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/sj.bjp.0705339","article-title":"An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells","volume":"139","author":"Kurikawa","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib24","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00004872-200106001-00004","article-title":"The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction","volume":"19","author":"Laeis","year":"2001","journal-title":"J. Hypertens., Suppl."},{"key":"10.1016\/j.ejphar.2008.04.028_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1096\/fasebj.11.11.9285483","article-title":"The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: a link between oxidative injury and fibrosclerosis","volume":"11","author":"Leonarduzzi","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2008.04.028_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jc.84.5.1513","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2008.04.028_bib27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/01.RES.83.12.1182","article-title":"Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases","volume":"83","author":"Matsubara","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2008.04.028_bib28","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/CIRCULATIONAHA.105.573709","article-title":"Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice","volume":"112","author":"Matsuno","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.028_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2008.04.028_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1291\/hypres.27.293","article-title":"Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats","volume":"27","author":"Okada","year":"2004","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2008.04.028_bib31","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00125-003-1099-3","article-title":"Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model","volume":"46","author":"Ota","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2008.04.028_bib32","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","article-title":"Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis","volume":"132","author":"Ota","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib33","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.0000141736.76561.78","article-title":"Renin\u2013angiotensin system and angiotensin receptor blockers in the metabolic syndrome","volume":"110","author":"Prasad","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.028_bib34","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2008.04.028_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/gast.2001.27126","article-title":"Nonalcoholic steatohepatitis","volume":"121","author":"Reid","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.04.028_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2003.09.020","article-title":"The methionine\u2013choline deficient dietary model of steatohepatitis does not exhibit insulin resistance","volume":"40","author":"Rinella","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib37","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of steatohepatitis in mice fed a lipogenic methionine choline deficient (MCD) diet","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2008.04.028_bib38","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"Schupp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.04.028_bib39","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ki.1995.156","article-title":"Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat","volume":"47","author":"Shanmugam","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2008.04.028_bib40","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.04.028_bib41","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1161\/01.HYP.0000125142.41703.64","article-title":"Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice","volume":"43","author":"Shiuchi","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2008.04.028_bib42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s00125-004-1366-y","article-title":"Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients","volume":"47","author":"Takamura","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2008.04.028_bib43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejphar.2007.11.016","article-title":"Cross talk of tumor necrosis factor-alpha and the renin\u2013angiotensin system in tumor necrosis factor-alpha-induced plasminogen activator inhibitor-1 production from hepatocytes","volume":"579","author":"Takeshita","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/00004872-200018110-00011","article-title":"The contribution of skeletal muscle tumor necrosis factor-alpha to insulin resistance and hypertension in fructose-fed rats","volume":"18","author":"Togashi","year":"2000","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2008.04.028_bib45","doi-asserted-by":"crossref","first-page":"12490","DOI":"10.1073\/pnas.93.22.12490","article-title":"Cross-talk between the insulin and angiotensin signaling systems","volume":"93","author":"Velloso","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.04.028_bib46","doi-asserted-by":"crossref","first-page":"35137","DOI":"10.1074\/jbc.M601320200","article-title":"Angiotensin II induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells","volume":"281","author":"Wei","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.04.028_bib47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jhep.2005.02.034","article-title":"Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice","volume":"43","author":"Yang","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2008.04.028_bib48","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","author":"Yokohama","year":"2004","journal-title":"Hepatology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990800397X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990800397X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T13:06:12Z","timestamp":1557493572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990800397X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":49,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S001429990800397X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.04.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}